During a live event, Kathleen A. Dorritie, MD, discussed updated outcomes from the IsKia, MASTER, and CONCEPT clinical trials ...

About MRD Assessment Minimal residual disease (MRD) testing is emerging as an important tool in assessing treatment response and guiding therapeutic decisions in oncology. With advancements in ...

We're also seeing a halo effect from this decision in other disease states like CLL, where treatment advances are necessitating more sensitive MRD assessment in clinical trials. Additionally ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Earlier this week, Trump’s Republican administration told about 400 scientists working on the National Climate Assessment that ... two organizations joining to do this report “is a testament ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) ...

Natera has announced findings from a study evaluating its personalised tumour-informed molecular residual disease (MRD) test, ...

Madison researchers are developing a mobile app that could make renovations for aging in place easier to recommend.